IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2
Clinical trial NCT00770029 · COMPLETED
Trial details
- NCT number
- NCT00770029
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-03-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.